This inventor holds 1 USPTO granted patent and 9 published patent applications. Top assignee: Societe Des Produits Nestle S.a.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Innovations by Pascal Steiner in Neurological Treatments
Introduction
Pascal Steiner is an innovative inventor based in St. Louis, MO (US). He has made significant contributions to the field of neurological health through his research and inventions. His work focuses on developing compositions that can aid in the prevention and treatment of neurological diseases and conditions.
Latest Patents
Pascal Steiner holds a patent for "Compositions and methods containing N-acetylcystein and nicotinamide riboside for prevention and treatment of neurological diseases and conditions." This invention provides compositions that include at least one N-acetyl cysteine and at least one nicotinamide riboside. These compositions are designed for use in methods aimed at preventing and treating neurological diseases and conditions. The invention emphasizes maintaining or improving brain function, particularly addressing brain energy deficits. Additionally, it aims to enhance neurological recovery and regeneration following injury or surgery.
Career Highlights
Pascal Steiner is associated with the company Société des Produits Nestlé S.A., where he continues to contribute to advancements in health and nutrition. His work is pivotal in exploring new avenues for treating neurological disorders, showcasing his commitment to improving patient outcomes.
Collaborations
Some of his notable coworkers include Laura Trovo and Bernard Cuenoud, who collaborate with him in his research endeavors. Their combined expertise enhances the innovative potential of their projects.
Conclusion
Pascal Steiner's contributions to neurological health through his patented inventions highlight the importance of innovation in medical science. His work not only addresses critical health issues but also paves the way for future advancements in treatment methodologies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
